135 related articles for article (PubMed ID: 9296285)
1. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
[TBL] [Abstract][Full Text] [Related]
2. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
[TBL] [Abstract][Full Text] [Related]
3. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
[TBL] [Abstract][Full Text] [Related]
4. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Hybenová D; Majtán V
Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
[TBL] [Abstract][Full Text] [Related]
5. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
6. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Kentepozidis N; Antonopoulou A; Plachouras D; Tsaganos T; Giamarellou H
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):113-7. PubMed ID: 15698716
[TBL] [Abstract][Full Text] [Related]
8. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
Gerçeker AA; Otük G
Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
Hostacká A; Karelová E
Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
11. Netilmicin: in vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infections.
Bonfiglio G; Scuderi AC; Russo G
Chemotherapy; 2001; 47(2):117-22. PubMed ID: 11173813
[TBL] [Abstract][Full Text] [Related]
12. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
Lister PD; Wolter DJ
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S105-14. PubMed ID: 15712098
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of combinations of netilmicin with aztreonam against Pseudomonas aeruginosa.
Tumah H; Velonaki A; Michalitsianos D; Legakis N
Chemioterapia; 1987 Jun; 6(2 Suppl):128-9. PubMed ID: 3151332
[No Abstract] [Full Text] [Related]
14. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
Lister PD; Wolter DJ; Wickman PA; Reisbig MD
J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
[TBL] [Abstract][Full Text] [Related]
16. The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
Digranes A; Dibb WL; Ostervold B
Scand J Infect Dis Suppl; 1980; Suppl 23():30-3. PubMed ID: 6782655
[No Abstract] [Full Text] [Related]
17. Postantibiotic effects of subinhibitory concentrations of some antibiotics and their influence on Pseudomonas aeruginosa enzymic activity.
Hostacká A
Folia Microbiol (Praha); 1996; 41(1):39-42. PubMed ID: 9090822
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect and virulence factors depression induced by ciprofloxacin and by aminoglycosides in a clinical isolate of Pseudomonas aeruginosa.
Hostacka A
Zentralbl Bakteriol; 1996 Mar; 283(3):322-7. PubMed ID: 8861870
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on netilmicin in the treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa].
Murahashi I; Honda M; Maeda S; Takasaki E
Jpn J Antibiot; 1982 Aug; 35(8):1919-24. PubMed ID: 6818388
[TBL] [Abstract][Full Text] [Related]
20. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
Digranes A; Dibb WL; Benonisen E; Salveson A
Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
